Latest Commercialisation News

Lion Rock Minerals reported strong high-grade rutile and heavy mineral results at its Minta Project in Cameroon, expanding infill drilling and commissioning an in-country lab ahead of a maiden resource estimate targeted for H2 2026.

Imricor Medical Systems advanced FDA clearances and expanded clinical trials in Q1 CY26, positioning for commercial growth despite higher operating cash outflows.

QMines Limited’s latest drilling at Mount Mackenzie confirms a broad, structurally controlled high-grade gold system with multiple mineralised zones open at depth and along strike.

TMK Energy’s Gurvantes XXXV project hit a new daily gas production record exceeding 1,350 m³, confirming commercial desorption. The company secured $6 million in funding and regulatory approval to drill three new pilot wells and advance domestic gas use in Mongolia.

Jade Gas Holdings has secured Mongolian regulator approval for its TTCBM Project appraisal report, paving the way for reserve booking and submission of a development plan toward Mongolia's first significant gas operation.

Noble Helium has secured $12 million in a two-tranche placement to advance its North Rukwa helium project in Tanzania, positioning itself as a key player amid a global helium supply disruption caused by Middle East conflicts.

RLF AgTech has posted its strongest trading period with $18.3 million revenue year-to-date and positive EBITDA in March, driven by a strategic reset under new CEO Stuart Upton and a $4.5 million capital raise.

Firebird Metals has locked in exclusive global rights to key LMFP patents through 2045 and commissioned lithium-manganese-rich cathode equipment, progressing its Australian Demonstration Plant with a $2 million ARENA grant.

Elixir Energy has initiated fracture stimulation and flow testing at its Diona-1 well in Queensland’s Surat-Bowen Basin, aiming to confirm a larger gas resource footprint within the Taroom Trough. The well’s proximity to existing infrastructure offers a swift route to market if results prove positive.

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.

Biome Australia has taken a significant step in its innovation journey by filing a patent for its next generation probiotic strain BMB18, with a clinical trial set to begin in Q4 FY26 in partnership with La Trobe University.